Production (Stage)
Kairos Pharma, Ltd.
KAPA
$0.5666
$0.093619.79%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 184.28% | -60.46% | 15,219.05% | -47.50% | -56.99% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 44.74% | 280.00% | -41.18% | -10.53% | 137.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -16.79% | 88.71% | -- | -- | -- |
| Total Current Assets | 45.12% | -12.08% | 12,378.95% | -35.59% | -41.58% |
|
|
|||||
| Total Current Assets | 45.12% | -12.08% | 12,378.95% | -35.59% | -41.58% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -18.02% | -15.27% | -13.25% | -11.70% | -10.47% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23.82% | -- | -- | 20.84% | 18.46% |
| Total Assets | 37.60% | 15.27% | 385.83% | 5.97% | 0.73% |
|
|
|||||
| Total Accounts Payable | -18.85% | -35.16% | -47.26% | 6.97% | 12.95% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 33.96% | 2,550.00% | 0.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -18.85% | -40.67% | -44.40% | 10.71% | 12.93% |
|
|
|||||
| Total Current Liabilities | -18.85% | -40.67% | -44.40% | 10.71% | 12.93% |
| Long-Term Debt | -- | -- | -- | 3.04% | 2.98% |
| Short-term Debt | -- | -- | 33.96% | 2,550.00% | 0.00% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -18.85% | -40.67% | -54.61% | 9.22% | 10.84% |
|
|
|||||
| Common Stock & APIC | 23.06% | 21.71% | 170.13% | 0.00% | 0.00% |
| Retained Earnings | -14.32% | -12.51% | -15.42% | -3.87% | -5.20% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 49.33% | 43.34% | 225.55% | -10.54% | -15.54% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 49.33% | 43.34% | 225.55% | -10.54% | -15.54% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 49.33% | 43.34% | 225.55% | -10.54% | -15.54% |
|
|
|||||